Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Marijuana for Pain, Insomnia, Depression, and Anxiety
NCT03224468Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2017
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cannabis in pain, Insomnia, major depressive disorder (MDD) and 1 more (2 arms), sponsored by Massachusetts General Hospital. Primary endpoints: Cannabis Use Disorder Symptoms at 12 weeks, Hospital Anxiety and Depression Scale - Depression at 12 weeks and 3 more. Started Jul 2017; status: completed.
02
Drugs
cannabis
03
Conditions
painInsomniamajor depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT03224468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03224468.